Simultaneous mapping of metabolites and individual macromolecular components via ultra‐short acquisition delay 1H MRSI in the brain at 7T

Short‐echo‐time proton MR spectra at 7T feature nine to 10 distinct macromolecule (MM) resonances that overlap with the signals of metabolites. Typically, a metabolite‐nulled in vivo MM spectrum is included in the quantification`s prior knowledge to provide unbiased metabolite quantification. However, this MM model may fail if MMs are pathologically altered. In addition, information about the individual MM peaks is lost. In this study, we aimed to create an improved MM model by parameterization of the in vivo MM spectrum into individual components, and to use this new model to quantify free induction decay MR spectroscopic imaging (FID‐MRSI) data.

[1]  Rolf Gruetter,et al.  Is the macromolecule signal tissue‐specific in healthy human brain? A 1H MRS study at 7 tesla in the occipital lobe , 2014, Magnetic resonance in medicine.

[2]  Peter Boesiger,et al.  Slice‐selective FID acquisition, localized by outer volume suppression (FIDLOVS) for 1H‐MRSI of the human brain at 7 T with minimal signal loss , 2009, NMR in biomedicine.

[3]  K. Uğurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.

[4]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[5]  Wolfgang Bogner,et al.  Mapping of brain macromolecules and their use for spectral processing of 1H-MRSI data with an ultra-short acquisition delay at 7T , 2015, NeuroImage.

[6]  K. Behar,et al.  Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain , 1996, Magnetic resonance in medicine.

[7]  Vinzenz Fleischer,et al.  Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging. , 2016, Radiology.

[8]  Wolfgang Bogner,et al.  Lipid suppression via double inversion recovery with symmetric frequency sweep for robust 2D‐GRAPPA‐accelerated MRSI of the brain at 7 T , 2015, NMR in biomedicine.

[9]  R Gruetter,et al.  Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. , 1999, Journal of magnetic resonance.

[10]  Peter B Barker,et al.  Comparison of brain gray and white matter macromolecule resonances at 3 and 7 Tesla , 2015, Magnetic resonance in medicine.

[11]  Tobias Kober,et al.  MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field , 2010, NeuroImage.

[12]  Peter R Luijten,et al.  Lipid suppression for brain MRI and MRSI by means of a dedicated crusher coil , 2015, Magnetic resonance in medicine.

[13]  M. Pomper,et al.  Quantitative proton magnetic resonance spectroscopic imaging: Regional variations in the corpus callosum and cortical gray matter , 2005, Journal of magnetic resonance imaging : JMRI.

[14]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[15]  Michael Erb,et al.  Proton magnetic resonance spectroscopy with metabolite nulling reveals regional differences of macromolecules in normal human brain , 2002, Journal of magnetic resonance imaging : JMRI.

[16]  R. Gruetter,et al.  Methodology of1H NMR spectroscopy of the human brain at very high magnetic fields , 2005, Applied magnetic resonance.

[17]  D. van Ormondt,et al.  SVD-based quantification of magnetic resonance signals , 1992 .

[18]  S Trattnig,et al.  Coil combination of multichannel MRSI data at 7 T: MUSICAL , 2013, NMR in biomedicine.

[19]  S. Confort-Gouny,et al.  Optimization of residual water signal removal by HLSVD on simulated short echo time proton MR spectra of the human brain. , 2001, Journal of magnetic resonance.

[20]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[21]  Rolf Gruetter,et al.  Quantification of in vivo short echo-time proton magnetic resonance spectra at 14.1 T using two different approaches of modelling the macromolecule spectrum , 2009 .

[22]  Anke Henning,et al.  Characterization of the macromolecular baseline with a metabolite-cycled double-inversion recovery sequence in the human brain at 9.4T , 2016 .

[23]  S. Provencher.  Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[24]  Rolf Gruetter,et al.  Quantification of the neurochemical profile using simulated macromolecule resonances at 3 T , 2013, NMR in biomedicine.

[25]  Hans Hoogduin,et al.  High‐field MRS of the human brain at short TE and TR , 2011, NMR in biomedicine.

[26]  Hamid Dehghani,et al.  Influence of macromolecule baseline on 1H MR spectroscopic imaging reproducibility , 2016, Magnetic resonance in medicine.

[27]  Hyeonjin Kim,et al.  Parameterization of spectral baseline directly from short echo time full spectra in 1H‐MRS , 2017, Magnetic resonance in medicine.

[28]  U Klose,et al.  Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.

[29]  Klaus Scheffler,et al.  Fast and efficient free induction decay MR spectroscopic imaging of the human brain at 9.4 Tesla , 2017, Magnetic resonance in medicine.

[30]  Rolf Gruetter,et al.  1H NMR spectroscopy of rat brain in vivo at 14.1Tesla: improvements in quantification of the neurochemical profile. , 2008, Journal of magnetic resonance.

[31]  Rolf Gruetter,et al.  In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1H magnetic resonance spectroscopy, post‐processing and metabolite quantification at 14.1 T , 2014, Journal of neurochemistry.

[32]  Rolf Gruetter,et al.  Handling macromolecule signals in the quantification of the neurochemical profile. , 2012, Journal of Alzheimer's disease : JAD.

[33]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[34]  W. Bogner,et al.  High‐resolution mapping of human brain metabolites by free induction decay 1H MRSI at 7 T , 2012, NMR in Biomedicine.

[35]  C Boesch,et al.  Characterization of the macromolecule baseline in localized 1H‐MR spectra of human brain , 2001, Magnetic resonance in medicine.

[36]  Wolfgang Bogner,et al.  Ultra-high resolution brain metabolite mapping at 7 T by short-TR Hadamard-encoded FID-MRSI , 2016, NeuroImage.

[37]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[38]  Wolfgang Grodd,et al.  Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.

[39]  David Bonekamp,et al.  Regional apparent metabolite concentrations in young adult brain measured by 1H MR spectroscopy at 3 Tesla , 2008, Journal of magnetic resonance imaging : JMRI.

[40]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[41]  L. Axel,et al.  Rapid B1+ mapping using a preconditioning RF pulse with TurboFLASH readout , 2010, Magnetic resonance in medicine.

[42]  D L Rothman,et al.  Spectroscopic Assessment of Alterations in Macromolecule and Small-Molecule Metabolites in Human Brain After Stroke , 2001, Stroke.

[43]  U Klose,et al.  Mapping of the radio frequency magnetic field with a MR snapshot FLASH technique. , 1992, Medical physics.

[44]  Fawzi Boumezbeur,et al.  Metabolite and macromolecule T1 and T2 relaxation times in the rat brain in vivo at 17.2T , 2016, Magnetic resonance in medicine.